Cargando…

Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension

OBJECTIVE: To demonstrate single abobotulinumtoxinA injection efficacy in lower limb vs placebo for adults with chronic hemiparesis and assess long-term safety and efficacy of repeated injections. METHODS: In a multicenter, double-blind, randomized, placebo-controlled, single-cycle study followed by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gracies, Jean-Michel, Esquenazi, Alberto, Brashear, Allison, Banach, Marta, Kocer, Serdar, Jech, Robert, Khatkova, Svetlana, Benetin, Ján, Vecchio, Michele, McAllister, Peter, Ilkowski, Jan, Ochudlo, Stanislaw, Catus, France, Grandoulier, Anne Sophie, Vilain, Claire, Picaut, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705248/ https://www.ncbi.nlm.nih.gov/pubmed/29093068 http://dx.doi.org/10.1212/WNL.0000000000004687

Ejemplares similares

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017)

The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis
por: Gracies, Jean-Michel, et al.
Publicado: (2021)

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat‐treatment study
por: Delgado, Mauricio R, et al.
Publicado: (2020)

Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy
por: Delgado, Mauricio R., et al.
Publicado: (2017)

AbobotulinumtoxinA (Dysport(®)) Improves Function According to Goal Attainment in Children With Dynamic Equinus Due to Cerebral Palsy
por: Tilton, Ann, et al.
Publicado: (2017)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2016)

AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol
por: Esquenazi, Alberto, et al.
Publicado: (2021)

The Practical Use of AbobotulinumtoxinA in Aesthetics
por: Kane, Michael A. C., et al.
Publicado: (2017)

New Uses of AbobotulinumtoxinA in Aesthetics
por: Schlessinger, Joel, et al.
Publicado: (2017)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020)

AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review
por: Schnitzler, Alexis, et al.
Publicado: (2022)

AbobotulinumtoxinA: A 25-Year History
por: Monheit, Gary D., et al.
Publicado: (2017)

When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
por: Gracies, Jean-Michel, et al.
Publicado: (2020)

Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018)

AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018)

Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport)
por: Dover, Jeffrey S.
Publicado: (2017)

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
por: Nestor, Mark, et al.
Publicado: (2017)

Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
por: Trosch, Richard M., et al.
Publicado: (2020)

Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia
por: Samotus, Olivia, et al.
Publicado: (2023)

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
por: Nomikos, Nikolaos, et al.
Publicado: (2023)

Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler
por: Cartier, Hugues, et al.
Publicado: (2020)

Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2019)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review
por: Cohen, Joel L., et al.
Publicado: (2017)

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
por: Muthukumar, Madhusubramanian, et al.
Publicado: (2017)

Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
por: Fasano, Alfonso, et al.
Publicado: (2020)

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
por: Abogunrin, Seye, et al.
Publicado: (2015)

Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
por: Wanitphakdeedecha, Rungsima, et al.
Publicado: (2020)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA
por: Hefter, Harald, et al.
Publicado: (2020)

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy
por: Di Gregorio, Carlo, et al.
Publicado: (2023)

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
por: Kong, Keng He, et al.
Publicado: (2017)

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2022)

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial
por: Ascher, Benjamin, et al.
Publicado: (2020)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gf8nb2boq6fiiivqiqq8elitkm